Colgate-Palmolive (NYSE:CL) Shares Sold by Ashton Thomas Private Wealth LLC

Ashton Thomas Private Wealth LLC trimmed its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 3.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,251 shares of the company’s stock after selling 465 shares during the quarter. Ashton Thomas Private Wealth LLC’s holdings in Colgate-Palmolive were worth $1,373,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vest Financial LLC lifted its stake in Colgate-Palmolive by 25.1% during the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after buying an additional 74,337 shares in the last quarter. Central Bank & Trust Co. lifted its stake in Colgate-Palmolive by 22.1% during the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its stake in Colgate-Palmolive by 9.2% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after buying an additional 910 shares in the last quarter. Sarasin & Partners LLP lifted its stake in Colgate-Palmolive by 1.2% during the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after buying an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC lifted its stake in Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after buying an additional 172 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Royal Bank of Canada upped their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday, April 29th. Wells Fargo & Company upped their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. BNP Paribas began coverage on Colgate-Palmolive in a report on Monday, June 24th. They issued an “outperform” rating and a $109.00 target price on the stock. Stifel Nicolaus upped their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. Finally, Bank of America upped their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $93.83.

View Our Latest Stock Analysis on CL

Insider Activity

In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of CL traded up $0.67 during mid-day trading on Friday, hitting $96.56. The company’s stock had a trading volume of 733,765 shares, compared to its average volume of 4,453,009. Colgate-Palmolive has a one year low of $67.62 and a one year high of $99.08. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market capitalization of $79.22 billion, a PE ratio of 30.35, a price-to-earnings-growth ratio of 3.53 and a beta of 0.39. The stock’s 50-day moving average is $94.44 and its two-hundred day moving average is $88.01.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the business earned $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.